Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $30.04-$78.48 |
Market Cap | $4.7B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $38.3M |
Revenue Growth (YoY) | 47.7% |
Gross Profit (12 Mos) | -$430.6M |
Diluted EPS | -$5.54 |
News
See moreYahoo Finance • 5 days ago
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
Yahoo Finance • 5 days ago
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Yahoo Finance • 6 days ago
RBC Capital Lifts CRISPR Therapeutics (CRSP) Target to $50, Keeps Sector Perform
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |
